- call +1-201-465-4211
- email sales@mrinsights.biz
The biocellular therapy industry includes upstream cell storage, midstream cell technology development, and downstream cell therapy.
Scope of the Report:
This report focuses on the Biotherapeutics Cell Line in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The downstream of the biological cell therapy industry chain - cell therapy, the implementation of the main body is the top three hospitals; there are two types of downstream industry models: one for the top three hospitals to carry out this business, the other for the top three hospitals and enterprises cooperation, the company provides Technical services and technical support, the hospital provides a clinical platform to implement treatment behavior.
The worldwide market for Biotherapeutics Cell Line is expected to grow at a CAGR of roughly 7.8% over the next five years, will reach 88 million US$ in 2023, from 56 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Becton Dickinson
Beckman Coulter
Boehringer Ingelheim Pharma
CMC Biologics
Catalent
Lonza Group
ProBioGen
Partec
SAFC
Sony Biotechnology
Selexis
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Single Cell Cloning
Transfection and Selection
Market Segment by Applications, can be divided into
Cancer
Other
There are 15 Chapters to deeply display the global Biotherapeutics Cell Line market.
Chapter 1, to describe Biotherapeutics Cell Line Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biotherapeutics Cell Line, with sales, revenue, and price of Biotherapeutics Cell Line, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biotherapeutics Cell Line, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biotherapeutics Cell Line market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biotherapeutics Cell Line sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biotherapeutics Cell Line Introduction
1.2 Market Analysis by Type
1.2.1 Single Cell Cloning
1.2.2 Transfection and Selection
1.3 Market Analysis by Applications
1.3.1 Cancer
1.3.2 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Becton Dickinson
2.1.1 Business Overview
2.1.2 Biotherapeutics Cell Line Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Becton Dickinson Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Beckman Coulter
2.2.1 Business Overview
2.2.2 Biotherapeutics Cell Line Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Beckman Coulter Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim Pharma
2.3.1 Business Overview
2.3.2 Biotherapeutics Cell Line Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Pharma Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 CMC Biologics
2.4.1 Business Overview
2.4.2 Biotherapeutics Cell Line Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CMC Biologics Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Catalent
2.5.1 Business Overview
2.5.2 Biotherapeutics Cell Line Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Catalent Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lonza Group
2.6.1 Business Overview
2.6.2 Biotherapeutics Cell Line Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lonza Group Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 ProBioGen
2.7.1 Business Overview
2.7.2 Biotherapeutics Cell Line Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ProBioGen Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Partec
2.8.1 Business Overview
2.8.2 Biotherapeutics Cell Line Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Partec Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SAFC
2.9.1 Business Overview
2.9.2 Biotherapeutics Cell Line Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 SAFC Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sony Biotechnology
2.10.1 Business Overview
2.10.2 Biotherapeutics Cell Line Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sony Biotechnology Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Selexis
2.11.1 Business Overview
2.11.2 Biotherapeutics Cell Line Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Selexis Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Thermo Fisher Scientific
2.12.1 Business Overview
2.12.2 Biotherapeutics Cell Line Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Thermo Fisher Scientific Biotherapeutics Cell Line Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biotherapeutics Cell Line Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Biotherapeutics Cell Line Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biotherapeutics Cell Line Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Biotherapeutics Cell Line Manufacturer Market Share in 2017
3.3.2 Top 6 Biotherapeutics Cell Line Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biotherapeutics Cell Line Market Analysis by Regions
4.1 Global Biotherapeutics Cell Line Sales, Revenue and Market Share by Regions
4.1.1 Global Biotherapeutics Cell Line Sales and Market Share by Regions (2013-2018)
4.1.2 Global Biotherapeutics Cell Line Revenue and Market Share by Regions (2013-2018)
4.2 North America Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
4.3 Europe Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
4.5 South America Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
5 North America Biotherapeutics Cell Line by Countries
5.1 North America Biotherapeutics Cell Line Sales, Revenue and Market Share by Countries
5.1.1 North America Biotherapeutics Cell Line Sales and Market Share by Countries (2013-2018)
5.1.2 North America Biotherapeutics Cell Line Revenue and Market Share by Countries (2013-2018)
5.2 United States Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
5.3 Canada Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
5.4 Mexico Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
6 Europe Biotherapeutics Cell Line by Countries
6.1 Europe Biotherapeutics Cell Line Sales, Revenue and Market Share by Countries
6.1.1 Europe Biotherapeutics Cell Line Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Biotherapeutics Cell Line Revenue and Market Share by Countries (2013-2018)
6.2 Germany Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
6.3 UK Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
6.4 France Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
6.5 Russia Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
6.6 Italy Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biotherapeutics Cell Line by Countries
7.1 Asia-Pacific Biotherapeutics Cell Line Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biotherapeutics Cell Line Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Biotherapeutics Cell Line Revenue and Market Share by Countries (2013-2018)
7.2 China Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
7.3 Japan Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
7.4 Korea Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
7.5 India Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
8 South America Biotherapeutics Cell Line by Countries
8.1 South America Biotherapeutics Cell Line Sales, Revenue and Market Share by Countries
8.1.1 South America Biotherapeutics Cell Line Sales and Market Share by Countries (2013-2018)
8.1.2 South America Biotherapeutics Cell Line Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
8.3 Argentina Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
8.4 Colombia Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biotherapeutics Cell Line by Countries
9.1 Middle East and Africa Biotherapeutics Cell Line Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biotherapeutics Cell Line Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Biotherapeutics Cell Line Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
9.3 UAE Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
9.4 Egypt Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
9.5 Nigeria Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
9.6 South Africa Biotherapeutics Cell Line Sales and Growth Rate (2013-2018)
10 Global Biotherapeutics Cell Line Market Segment by Type
10.1 Global Biotherapeutics Cell Line Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biotherapeutics Cell Line Sales and Market Share by Type (2013-2018)
10.1.2 Global Biotherapeutics Cell Line Revenue and Market Share by Type (2013-2018)
10.2 Single Cell Cloning Sales Growth and Price
10.2.1 Global Single Cell Cloning Sales Growth (2013-2018)
10.2.2 Global Single Cell Cloning Price (2013-2018)
10.3 Transfection and Selection Sales Growth and Price
10.3.1 Global Transfection and Selection Sales Growth (2013-2018)
10.3.2 Global Transfection and Selection Price (2013-2018)
11 Global Biotherapeutics Cell Line Market Segment by Application
11.1 Global Biotherapeutics Cell Line Sales Market Share by Application (2013-2018)
11.2 Cancer Sales Growth (2013-2018)
11.3 Other Sales Growth (2013-2018)
12 Biotherapeutics Cell Line Market Forecast (2018-2023)
12.1 Global Biotherapeutics Cell Line Sales, Revenue and Growth Rate (2018-2023)
12.2 Biotherapeutics Cell Line Market Forecast by Regions (2018-2023)
12.2.1 North America Biotherapeutics Cell Line Market Forecast (2018-2023)
12.2.2 Europe Biotherapeutics Cell Line Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biotherapeutics Cell Line Market Forecast (2018-2023)
12.2.4 South America Biotherapeutics Cell Line Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biotherapeutics Cell Line Market Forecast (2018-2023)
12.3 Biotherapeutics Cell Line Market Forecast by Type (2018-2023)
12.3.1 Global Biotherapeutics Cell Line Sales Forecast by Type (2018-2023)
12.3.2 Global Biotherapeutics Cell Line Market Share Forecast by Type (2018-2023)
12.4 Biotherapeutics Cell Line Market Forecast by Application (2018-2023)
12.4.1 Global Biotherapeutics Cell Line Sales Forecast by Application (2018-2023)
12.4.2 Global Biotherapeutics Cell Line Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biotherapeutics Cell Line Picture
Table Product Specifications of Biotherapeutics Cell Line
Figure Global Sales Market Share of Biotherapeutics Cell Line by Types in
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
